Moderna Inc (MRNA)

[jondoeuk]

IBRX uses NK-92, an immortalised cell line that has the characteristics of NK cells https://pubmed.ncbi.nlm.nih.gov/8152260/

As a transformed cell line, however, must be irradiated prior to administration. In previous trials, this is one of the reasons for the limited persistence observed (detectable for only 48 hours) https://www.isct-cytotherapy.org/article/S1465-3249(13)00603-8/abstract